{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-297085","form_type":"8-K","ticker":"SMNR","cik":"0001913577","company_name":"Semnur Pharmaceuticals, Inc.","filed_at":"2026-07-07T14:38:16+00:00","discovered_at":"2026-07-07T14:42:00.377522+00:00","generated_at":"2026-07-07T14:42:12.424040+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Semnur signs binding term sheet for $100M strategic investment from iHolding Group at $10/share","bullets":["iHolding to purchase $100M of newly issued common stock at $10/share (~10M shares).","Proceeds to fund SEMDEXA Phase 3 program, product development, acquisitions, working capital.","Investment subject to due diligence, definitive agreements, board/stockholder/regulatory approvals.","Semnur is a majority-owned subsidiary of Scilex Holding Company.","No assurance of consummation; risks of termination or litigation."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-297085","json":"https://secwatch.observer/filing/0001193125-26-297085.json","markdown":"https://secwatch.observer/filing/0001193125-26-297085.md","text":"https://secwatch.observer/filing/0001193125-26-297085.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1913577/000119312526297085/0001193125-26-297085-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1913577/000119312526297085/smnr-20260703.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-07T14:42:12.424040+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}